Concepedia

Author

Bodo Haas

Federal Institute for Drugs and Medical DevicesORCID

Also Known As

B Haas, B. Haas, Bodo Haas

42

Publications

1.4K

Citations

14

H-Index

51

Concepts

All Affiliations

Federal Institute for Drugs and Medical DevicesUniversity of BonnUniversity of Applied Sciences KaiserslauternMax Planck Institute of BiochemistryUniversity of Regensburg
BH

About

Bodo Haas is an author at Federal Institute for Drugs and Medical Devices specializing in medicine, cell biology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

457

2

Cell Biology

5

5

390

3

Health Sciences

1

1

137

4

Biochemistry

1

1

137

5

Biostatistics

1

1

56

Bodo Haas

×

15

Publications

1.2K

Citations

12

H-Index

YearCitations

miR-155 regulates differentiation of brown and beige adipocytes via a bistable circuit

Yong Chen, Franziska Siegel, Stefanie Kipschull,

Nature Communications

2013

275

Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma

Ramin Massoumi, Silke Kuphal, Claus Hellerbrand,

The Journal of Experimental Medicine

2009

205

Increased cGMP promotes healthy expansion and browning of white adipose tissue

Michaela M. Mitschke, Linda S. Hoffmann, Thorsten Gnad,

The FASEB Journal

2013

141

Protein Kinase G Controls Brown Fat Cell Differentiation and Mitochondrial Biogenesis

Bodo Haas, P. Mayer, Katja Jennissen,

Science Signaling

2009

137

Efficacy, safety and regulatory status of SGLT2 inhibitors: focus on canagliflozin

Bodo Haas, Niels Eckstein, Vladlena Pfeifer,

Nutrition and Diabetes

2014

110

Cyclic GMP and Protein Kinase G Control a Src-Containing Mechanosome in Osteoblasts

Hema Rangaswami, Raphaela Schwappacher, Nisha Marathe,

Science Signaling

2010

94

Determining recommended acceptable intake limits for N-nitrosamine impurities in pharmaceuticals: Development and application of the Carcinogenic Potency Categorization Approach (CPCA)

Naomi L. Kruhlak, Marianne Schmidt, Roland Froetschl,

Regulatory Toxicology and Pharmacology

2024

56

Inhibition of the PI3K but not the MEK/ERK pathway sensitizes human glioma cells to alkylating drugs

Bodo Haas, Veronika Klinger, Christina Keksel,

Cancer Cell International

2018

41

Clinical pharmacology of tyrosine kinase inhibitors becoming generic drugs: the regulatory perspective

Niels Eckstein, Lea Röper, Bodo Haas,

Journal of Experimental & Clinical Cancer Research

2014

40

Targeting adipose tissue

Bodo Haas, Paul Schlinkert, P. Mayer,

Diabetology & Metabolic Syndrome

2012

40

Page 1